Valuation: Incyte Corporation

Market Cap 24.45B 21.17B 19.74B 18.15B 34.27B 2,324B 34.65B 232B 91.03B 1,163B 91.81B 89.79B 3,852B P/E 2026 *
53.8x
P/E 2027 * 16.8x
Enterprise Value 20.2B 17.49B 16.31B 15B 28.31B 1,920B 28.63B 192B 75.2B 961B 75.85B 74.18B 3,182B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.98x
Free-Float
98.13%
Yield 2026 *
-
Yield 2027 * -
1 day+0.03%
1 week-4.76%
Current month+1.28%
1 month+4.70%
3 months+24.19%
6 months+17.80%
Current year+22.56%
1 week 117
Extreme 117
126.5
1 month 110.56
Extreme 110.56
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 76.45
Extreme 76.45
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
23/7/26 Free

Chief Technology Officer

15,425 0.0077%
23/7/26 Free

EVP, Head of Incyte Intl

28,921 0.0145%
16/7/26 Free

EVP & Chief Scientific Officer

46,244 0.0231%
Change 5-day change 1-year change 3-year change Capi.($)
+0.00%-4.76%+55.74%+86.49% 24.45B
+1.77%+11.60%+36.17%+0.17% 75.96B
+2.64%-8.65%+22.67%+186.79% 49.03B
+1.02%-3.74%-7.47%+21.83% 47.88B
+1.42%+9.32%-50.68%-50.72% 43.39B
+0.17%-0.11%+57.28%-22.94% 30.8B
-0.25%+4.28%+106.84%-43.85% 22.75B
+4.15%+0.44%-2.80%+175.30% 19.24B
+0.26%-1.70%+66.88%+165.25% 16.04B
+1.05%-6.85%+60.29%+117.79% 15.87B
Average +1.25%-1.38%+34.49%+63.61% 34.54B
Weighted average by Cap. +1.39%+0.26%+25.58%+47.25%

Financials

2026 *2027 *
Net sales 5.94B 5.15B 4.8B 4.41B 8.33B 565B 8.42B 56.38B 22.13B 283B 22.32B 21.83B 936B 6.26B 5.42B 5.05B 4.64B 8.77B 595B 8.87B 59.35B 23.29B 298B 23.49B 22.98B 986B
Net income 466M 403M 376M 346M 653M 44.27B 660M 4.42B 1.73B 22.15B 1.75B 1.71B 73.37B 1.47B 1.27B 1.19B 1.09B 2.06B 140B 2.08B 13.95B 5.48B 69.96B 5.52B 5.4B 232B
Net Debt -4.25B -3.68B -3.43B -3.16B -5.96B -404B -6.02B -40.31B -15.82B -202B -15.96B -15.61B -670B -5.81B -5.03B -4.69B -4.32B -8.15B -553B -8.24B -55.14B -21.64B -277B -21.83B -21.35B -916B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
06/08/26 USD 120.96 +0.30% 802,221
04/08/26 USD 120.60 +1.83% 2,077,654
03/08/26 USD 118.43 -0.91% 1,419,133
31/07/26 USD 119.52 -2.82% 1,830,263
30/07/26 USD 122.99 -3.23% 2,628,292
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
120.60USD
Average target price
124.96USD
Spread / Average Target
+3.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock